The Original and Only Clinically-Proven Modified Citrus Pectin. PectaSol-C is the most advanced and effective Modified Citrus Pectin available. Over 60 published studies show PectaSol-C delivers unparalleled support for total-body health and aging, with critical benefits to key organs and systems.*
Safely kill cancer cells with watercress NaturalHealth365
Great news for cancer patients. Science reveals that eating watercress can inhibit and kill cancer cells safely and effectively without harming the body.
Covering Up The Causes of Breast Cancer Since 1985 AstraZeneca's
Did you know that AstraZeneca, manufacturer of two blockbuster breast cancer drugs (one of which is classified as a known human carcinogen), is behind Breast Cancer Awareness Month?
Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer - PubMed
We show that treatment with the FDA-approved anti-parasitic drug ivermectin induces immunogenic cancer cell death (ICD) and robust T cell infiltration into breast tumors. As an allosteric modulator of the ATP/P2X4/P2X7 axis which operates in both cancer and immune cells, ivermectin also selectively …
Welcome To Breast Cancer Conqueror - Breast Cancer Conqueror
About Dr V Dr. V Speaks 7 Essentials Coaches Shop Coaching Programs Private Coaching Success Stories Blog Podcasts Recipes Retreats Conquer Together Sarasota Contact is ... Read More
Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo - PubMed
Glioma, the most predominant primary malignant brain tumor, remains uncured due to the absence of effective treatments. Hence, it is imperative to develop successful therapeutic agents. This study aimed to explore the antitumor effects and mechanisms of ivermectin (IVM) in glioma cells in vitro and …
Ivermectin, a potential anticancer drug derived from an antiparasitic drug - PMC
Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer cells. This may be related to the regulation of multiple signaling pathways by ivermectin through PAK1 kinase. ...
Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin - PubMed
Ivermectin, a dihydro derivative of avermectin (AVM), was introduced into the veterinary, agricultural and aquaculture markets for animal health in 1981. Ivermectin was soon adopted in 1987 as a human medicine that was originally used for the treatment of onchocerciasis, a parasitic infection. Since …
Study suggests association between consuming artificial sweeteners and increased cancer risk -- ScienceDaily
Artificial sweeteners reduce added sugar content and corresponding calories while maintaining sweetness. A new study suggests that some artificial sweeteners are associated with increased cancer risk.
Many people who are diagnosed with cancer are told that they need to have surgery, chemotherapy or radiation treatments. They are often told that "There is nothing else they can do."
Is There A Cure for Skin Cancer - Iodine and Chlorine Dioxide to the Rescue
“I had three hard, very heavy tumors, so big that they almost prevented me from breathing. Then, at night, while sleeping, I had blood that would get into my nose and choke me. After two weeks of chlorine dioxide treatments using CDS [protocols C and D], I felt that the tumors were drying up more... View Article
Hitting the Bull’s-Eye in Metastatic Cancers is the name of an interesting research paper published in the journal Pharmaceuticals in 2015. Its abstract reads: “Tumor metastases that impede the function of vital organs are a major cause of cancer-related mortality. Mitochondrial oxidative stress induced by hypoxia, low nutrient levels, or other stresses, such as genotoxic... View Article
Six-month low level chlorine dioxide gas inhalation toxicity study with two-week recovery period in rats Journal of Occupational Medicine and Toxicology Full Text
Background Chlorine dioxide (CD) gas has a potent antimicrobial activity at extremely low concentration and may serve as a new tool for infection control occupationally as well as publicly. However, it remains unknown whether the chronic exposure of CD gas concentration effective against microbes is safe. Therefore, long-term, low concentration CD gas inhalation toxicity was studied in rats as a six-month continuous whole-body exposure followed by a two-week recovery period, so as to prove that the CD gas exposed up to 0.1 ppm (volume ratio) is judged as safe on the basis of a battery of toxicological examinations. Methods CD gas at 0.05 ppm or 0.1 ppm for 24 hours/day and 7 days/week was exposed to rats for 6 months under an unrestrained condition with free access to chow and water in a chamber so as to simulate the ordinary lifestyle in human. The control animals were exposed to air only. During the study period, the body weight as well as the food and water consumptions were recorded. After the 6-month exposure and the 2-week recovery period, animals were sacrificed and a battery of toxicological examinations, including biochemistry, hematology, necropsy, organ weights and histopathology, were performed. Results Well regulated levels of CD gas were exposed throughout the chamber over the entire study period. No CD gas-related toxicity sign was observed during the whole study period. No significant difference was observed in body weight gain, food and water consumptions, and relative organ weight. In biochemistry and hematology examinations, changes did not appear to be related to CD gas toxicity. In necropsy and histopathology, no CD gas-related toxicity was observed even in expected target respiratory organs. Conclusions CD gas up to 0.1 ppm, exceeding the level effective against microbes, exposed to whole body in rats continuously for six months was not toxic, under a condition simulating the conventional lifestyle in human.
'Vaccine-Induced Cancer' Chlorine Dioxide To The Rescue
We now have an inconceivable rise in cancer rates caused by COVID vaccines. Early in 2022, Senator Ron Johnson hosted a conference in Washington D.C. called “Second Opinion.” One of the speakers at this 5-hour recorded event last Monday was attorney Thomas Renz, who in the short time allotted to him, testified that three military... View Article